The Consortium conducts original research, serves students and faculty, and advances public dialogue and understanding on emerging issues at the intersection of science and society.
A week from today, the Center for Bioethics, a Consortium member, is hosting a Climate Forum that will focus on mitigating climate change and adapting for a better future for our environment and public health. Business and non-profit leaders, researchers, sustainability professionals, policy experts, students, and anyone interested in the intersection of public and private efforts to address climate change are invited. Listen and engage with two panels: one with experts from the policy, advocacy, and legal fields and another with Minnesota industry leaders from healthcare, consumer products, and commercial real estate. The event is from 10-4:30 at Mayo Memorial Auditorium; learn more and register here.
Consortium chair Susan M. Wolf and Dr. Ronald Petersen (Mayo Clinic) were interviewed yesterday about the practical, ethical and legal implications of new tools for early diagnosis of Alzheimer's disease. The interview was conducted by Kerri Miller of MPR News, and focuses on Dr. Petersen's recently published research, with Prof. Wolf weighing in on the nuances of translating it to clinical practice. Phone calls from people already diagnosed with Alzheimer's and those who have a family history of the disease illuminate the challenges of grappling with this heartbreaking illness. Listen to the entire interview here.
The John Simon Guggenheim Memorial Foundation has awarded Carl Elliott, MD, PhD, a fellowship in medicine and health. Prof. Elliott is on the faculty of the Center for Bioethics, a Consortium member, and in the Department of Pediatrics; he is also an affiliate faculty member in the Department of Philosophy and the School of Journalism and Mass Communications. During his Guggenheim Fellowship term, Elliott will be working on a book with the tentative title of Lonesome Whistle: Exposing Wrongdoing in Medical Research. Much of Elliott’s scholarship explores philosophical issues surrounding identity, authenticity and justice through the lens of biomedical technology. He is the author or editor of seven previous books, including White Coat, Black Hat: Adventures on the Dark Side of Medicine (Beacon, 2010) and Better than Well: American Medicine Meets the American Dream (Norton, 2003.) His articles have appeared in The New Yorker, The Atlantic Monthly, The London Review of Books, Mother Jones, The New York Times and The New England Journal of Medicine. Guggenheim Fellows are appointed on the basis of prior achievement and exceptional promise; this year, the competition attracted nearly 3,000 applicants.
The University of Minnesota's Clinical and Translational Science Institute (CTSI) has received a $42.6 million grant through the National Institutes of Health (NIH)-funded Clinical and Translational Science Award (CTSA) program. CTSI, a Consortium member, will use the funding to train and support researchers striving to make important discoveries that will improve Minnesotans’ health. The five-year award is effective March 30, 2018 through February 28, 2023 and is one of the University’s largest federal research grants; this is the second time CTSI has received this prestigious recognition. VP for Research Allen Levine notes, "CTSI has provided important clinical and translational research support across the University, including . . . for six technologies that have led to startup ventures in areas like microbiome analysis and cancer drug delivery." New to this grant is a mentored career development component that will allow trainees to develop the skills to translate research discoveries into clinical practice.